3 Reasons Why Hillman Solutions Corp. is a Must-Have Growth Stock

Hillman Solutions Corp. (HLMN) is a growth stock with a favorable Growth Score and top Zacks Rank. Its earnings growth is expected to be 12.9% this year, higher than the industry average of 8.6%. The company's cash flow growth is also 12.5%, higher than many of its peers. Its annualized cash flow growth rate has been 40.2% over the past 3-5 years, exceeding the industry average of 10%.

Hillman Solutions Corp. (HLMN), a leading provider of hardware products and merchandising solutions, has been making waves in the financial markets. The company's stock experienced a significant intraday rise of 3.41% on July 2, 2025, following the announcement of a Phase 1b clinical trial collaboration between Actuate Therapeutics, Inc. and UPMC Hillman Cancer Center. This trial, which involves elraglusib in combination with Incyte’s PD-1 inhibitor, retifanlimab, and modified FOLFIRINOX as frontline therapy in advanced pancreatic adenocarcinoma, is a positive development for Hillman Solutions Corp. [1]

In addition to this news, Hillman Solutions Corp. reported strong second-quarter (Q2) 2025 financial results. The company's revenue grew by 6.2% year-on-year to $402.8 million, exceeding analyst expectations of $392.4 million. The company's adjusted earnings per share (EPS) of $0.17 also beat analyst estimates by 18.5%, while adjusted EBITDA came in at $75.23 million, surpassing estimates by 18.7% [2].

The company's outlook for the full year is also promising. Hillman Solutions Corp. raised its full-year revenue guidance to $1.56 billion at the midpoint, an increase of 1.3% from its previous estimate. The company expects to navigate a challenging tariff environment by adjusting prices as needed and maintaining cost discipline. The dual faucet sourcing strategy, which aims to reduce reliance on China, is expected to support resilience and supply continuity [2].

Hillman Solutions Corp. is also expected to continue its strong performance in the Robotics and Digital Solutions segment, with the successful rollout of MinuteKey 3.5 kiosks. The company has already deployed over 2,200 machines in the field, with full deployment to the largest customers expected by the end of 2026 [2].

Investors should keep an eye on Hillman Solutions Corp.'s ability to manage tariff-related costs and maintain pricing actions to offset these costs. The company's dual faucet sourcing strategy and operational efficiency focus are expected to drive future performance.

References:
[1] https://www.ainvest.com/news/hillman-solutions-corp-shares-rise-3-41-intraday-actuate-therapeutics-announced-clinical-trial-collaboration-upmc-hillman-cancer-center-2508/
[2] https://finance.yahoo.com/news/hlmn-q2-deep-dive-tariff-033641018.html